Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 102-110

  Suliman, Mohamed E ^a   Divino Filho, José C ^a,b   Bárány, Peter ^a   Anderstam, Björn ^a   Lindholm, Bengt ^a   Bergström, Jonas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Erythrocyte; Folic acid; Haemodialysis; Homocysteine; Methionine loading test; Sulphur amino acids; Vitamin B6

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALBUMIN; BICARBONATE; CARBOXYLYASE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; CYSTEIC ACID; CYSTEINE; CYSTEINYLGLYCINE; DIURETIC AGENT; DRUG METABOLITE; FOLIC ACID; GAMMA GLUTAMYLCYSTEINE; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; METHYLENETETRAHYDROFOLIC ACID; METHYLTRANSFERASE; NITROGEN; PHOSPHATE BINDING AGENT; PROTEIN; PYRIDOXINE; SULFUR AMINO ACID; TAU PROTEIN; TAURINE; TETRAHYDROFOLIC ACID; THIOL DERIVATIVE; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG METABOLISM; ERYTHROCYTE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; LOADING TEST; LONG TERM CARE; MALE; METABOLIC DISORDER; METABOLIC REGULATION; PHARMACOLOGICAL PROCEDURES; PLASMA; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 0035160068     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.102     Document Type: Article

References (32)

1. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide
2. Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients
3. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
4. Quantitative assessment of plasma homocysteine as a risk factor for vascular disease
5. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
6. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
7. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients
8. Sulphur amino acids in plasma and muscle in patients with chronic renal failure: Evidence for taurine depletion
9. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients
10. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
11. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosyl-methionine of the remethylation and transsulfuration of homocysteine
12. Homocysteine metabolism
13. The effect of subnormal vitamin B-6 status on homocysteine metabolism
14. Hyperhomocysteinemia in terms of steady-state kinetics
15. Kinetic modeling in hemodialysis
16. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
17. Highly sensitive and simple liquid chromatographic determination in plasma of B6 vitamers, especially pyridoxal 5′-phosphate
18. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
19. Net uptake of plasma homocysteine by the rat kidney in vivo
20. No net renal extraction of homocysteine in fasting humans
21. Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: A cause for disturbed methylation reactions
22. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients
23. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
24. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia
25. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy
26. Reversal of hyperhomocyst(e)inaemia in chronic renal failure is folic or folinic acid the answer?
27. Plasma homocysteine in renal failure
28. Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients
29. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
30. Homocysteine and methionine metabolism in ESRD: A stable isotope study
31. Roles of plasma and erythrocytes in interorgan transport of amino acids in dogs
32. Dynamic relation between reduced, oxidized and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men